Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy

Cisplatin/pemetrexed chemotherapy has been established as a standard treatment in lung adenocarcinoma. However, the response to the cisplatin/pemetrexed combination varies considerably among patients due to individual variations. Thus, novel biomarkers are required to aid the prediction of the respo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: MOU, WENJUN, XUE, HUI, TONG, HONGLI, SUN, SHENGJIE, ZHANG, ZHUHONG, ZHANG, CHUNYAN, SUN, QIYU, DONG, JING, WEN, XINYU, YAN, GUANGTAO, TIAN, YAPING
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2014
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4049753/
https://ncbi.nlm.nih.gov/pubmed/24932291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.1988
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg